March 24, 2026

In Celebration of a Decades-Long Journey of Discovery and Innovation

On October 1, 2025, Benjamin L. Ebert, MD, PhD, celebrated the 1-year anniversary of being named President and Chief Executive Officer (CEO) of Dana-Farber Cancer Institute in Boston. He also holds th...

The ASCO Post

March 24, 2026

Forgotten Lessons From South Africa

On March 10, 2000, it was a cold Friday morning in Washington, DC. As usual, we the oncology fellows and faculty crowded into a conference room at the NIH Clinical Center in Building 10 for our weekly...

The ASCO Post

March 24, 2026

Reducing the Impact of Climate-Induced Events on Patients and Oncology Staff

Although 2023 made headlines as the hottest year in human history,1 drawing the world closer to breaching the goals outlined in the Paris Agreement to substantially reduce global greenhouse gas emissi...

The ASCO Post

March 17, 2026

2025 San Antonio Breast Cancer Symposium Recap

Harold Burstein, MD, PhD, summarizes important breakthroughs presented at the 2025 San Antonio Breast Cancer Symposium.

Dana-Farber

March 17, 2026

SABCS 2025 Highlights: Hormone Replacement Therapy for Breast Cancer

Harold Burstein, MD, PhD, and Wendy Y. Chen, MD, MPH, discuss research in hormone replacement therapy for breast cancer that was presented at the 2025 San Antonio Breast Cancer Symposium.

Dana-Farber

March 16, 2026

Cancer Surgery: How Can Doctors Set Realistic Patient Expectations About Results?

A Keck Medicine of USC breast surgeon shares best practices to keep patients informed about treatment steps and expectations.

Keck Medicine of USC

March 11, 2026

Many Titles, One Mission: Advancing Team-Based Care in Oncology

The ACP insists on using 'physician' over 'provider' to uphold the integrity of the healthcare system amidst growing physician shortages.

JADPRO

March 11, 2026

Nourishing Hope: Five Essential Nutrition Tips for Patients With Pancreatic Cancer

Discover how the early management of malnutrition and hydration in pancreatic cancer patients can enhance treatment outcomes and overall quality of life.

JADPRO

March 11, 2026

‘Prostate Screening Saved My Life’—Is That Really True in Most Cases?

Prostate specific antigen (PSA) screening remains one of the most controversial of “standard” medical practices. As recently as the 2026 Super Bowl, one of the more unusual TV advertisements, sponsore...

The ASCO Post

March 06, 2026

Clinical Trials May Misrepresent True Thromboembolic Risks From Cancer Drugs

Researchers have identified that the reporting of venous and arterial thrombotic events in cancer clinical trials is inconsistent and potentially inaccurate, according to a comments article published ...

The ASCO Post